Novast Laboratories Ltd · SZSE:301569

Novast Laboratories Ltd financial statements

Novast Laboratories Ltd's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in CNY

Income statement

LineFY2025FY2024FY2023FY2022
Revenue895.5M866.2M700.4M550.1M
Cost of revenue396.4M394.2M348.9M270.4M
Gross profit499.0M472.0M351.5M279.7M
Research and development101.0M101.7M88.7M102.9M
Selling, general and administrative167.5M280.0M447.6M198.2M
Operating income267.7M257.5M120.7M48.7M
Depreciation and amortization35.9M34.6M34.5M32.7M
EBITDA303.6M292.1M155.2M81.4M
Income before tax263.1M290.1M136.1M130.2M
Net income227.8M260.1M115.8M113.0M
Earnings per share, basic0.300.340.150.15

Balance sheet

LineFY2025FY2024FY2023FY2022
Cash and equivalents1.10B863.1M638.1M475.6M
Short-term investments100.2M146.2M170.4M228.1M
Receivables173.0M132.1M113.0M80.0M
Inventory214.6M228.0M262.0M262.6M
Current assets1.62B1.41B1.23B1.10B
Total assets2.29B2.05B1.75B1.53B
Accounts payable13.0M8.93M9.18M3.09M
Current liabilities166.6M162.8M112.0M83.6M
Total liabilities283.9M261.4M225.9M200.9M
Shareholders' equity2.01B1.79B1.53B1.33B
Shares outstanding757.9M757.9M757.9M757.9M

Cash flow

LineFY2025FY2024FY2023FY2022
Cash from operations322.6M267.0M200.9M209.2M
Capital spending-75.3M-105.9M-127.0M-69.8M
Free cash flow247.3M161.2M74.0M139.4M
Dividends paid-68.0M
Change in cash-10.6M60.5M-104.7K-16.7M